Kate McLaughlin, PhD
Kate McLaughlin, PhD, is Vice President, Health Advances, a strategy consulting firm for the healthcare industry. She joined the Health Advances team in 2009 and spearheads the firm’s Bioprocess and Research Tools Practice. Dr. McLaughlin helps innovators and investors find pressing market needs for new technologies to address through voice of the customer analysis, competitive landscape assessments, and scenario-based forecasting. Prior to joining Health Advances, Dr. McLaughlin received a PhD in Immunology from Harvard University and a Bachelor of Science in biology from Case Western Reserve University.